Literature DB >> 25317038

Misoprostol for pre-term labor induction in the second trimester: Role of medical history and clinical parameters for prediction of time to delivery.

Alexander di Liberto1, Jan Endrikat2, Sandra Frohn2, Erich Solomayer2, Kubilay Ertan3.   

Abstract

OBJECTIVE: Serious fetal malformations and/or chromosome aberrations detected by modern diagnostic tools in early pregnancy require discussions on induced abortion with pregnant women. Competent counseling includes prediction of the time needed for the whole abortion process. In an attempt to refine our predictions, we evaluated the impact of 11 medical history and clinical variables on time to delivery.
MATERIAL AND METHODS: We performed a retrospective chart analysis on 79 women submitted for pre-term abortion because of fetal anomalies. Abortion was induced by vaginal application of misoprostol (prostaglandine E1, Cytotec™, Pfizer, New York, USA). We investigated 11 medical history and clinical variables for their impact on the percentage of women delivering within 24 hours (primary endpoint) and on the mean induction-delivery time interval (secondary endpoint).
RESULTS: Fifty-three percent (42/79) of women delivered within 24 hours; 83.6% (66/79) delivered within 48 hours. A total of 83.3% of women with a history of late abortion delivered within 24 hours, whereas 50.7% without this history did. Mean induction-delivery time interval was 12.3 hours versus 35.5 hours, respectively. For history of early abortion, the figures were 65.2% versus 48.2% for delivery within 24 hours and 15.6 hours versus 32.5 hours for mean induction-delivery time interval. Current weight of fetus >500 g, weight of last previous newborn of ≤3500 g, previous pregnancies, premature rupture of membranes, and an elevated CRP of >0.5 mg/dL also cut time to delivery. Surprisingly, maternal and gestational age had no remarkable or consistent impact on the mean induction-delivery time interval. None of the differences reached statistical significance. Eighty-three percent of women needed 1000 μg or less for successful delivery.
CONCLUSION: Neither variables of medical history nor specific clinical variables allow for precise prediction of time to delivery in the second trimester. Certain parameters, however, show a trend to reduce the induction-delivery time interval. Our results might serve as initial guidance for patient counseling.

Entities:  

Keywords:  Misoprostol; labor induction; patient counseling; time to delivery

Year:  2014        PMID: 25317038      PMCID: PMC4195320          DOI: 10.5152/jtgga.2014.13034

Source DB:  PubMed          Journal:  J Turk Ger Gynecol Assoc        ISSN: 1309-0380


  9 in total

1.  Factors affecting the likelihood of successful induction after intravaginal misoprostol application for cervical ripening and labor induction.

Authors:  Deborah A Wing; Susan Tran; Richard H Paul
Journal:  Am J Obstet Gynecol       Date:  2002-06       Impact factor: 8.661

2.  Misoprostol and the debate over off-label drug use.

Authors:  Andrew D Weeks; Christian Fiala; Peter Safar
Journal:  BJOG       Date:  2005-03       Impact factor: 6.531

Review 3.  A systematic review of the ultrasound estimation of fetal weight.

Authors:  N J Dudley
Journal:  Ultrasound Obstet Gynecol       Date:  2005-01       Impact factor: 7.299

4.  Randomized, double-blind, placebo-controlled trial of vaginal misoprostol for management of early pregnancy failures.

Authors:  Margit S Lister; Lynn E T Shaffer; Jeffrey G Bell; Kathleen Q Lutter; Karin H Moorma
Journal:  Am J Obstet Gynecol       Date:  2005-10       Impact factor: 8.661

5.  Outcomes of second-trimester pregnancy terminations with misoprostol: comparing 2 regimens.

Authors:  Rodney K Edwards; Shireen M Sims
Journal:  Am J Obstet Gynecol       Date:  2005-08       Impact factor: 8.661

6.  Misoprostol is more efficacious for labor induction than prostaglandin E2, but is it associated with more risk?

Authors:  L Kolderup; L McLean; K Grullon; K Safford; S J Kilpatrick
Journal:  Am J Obstet Gynecol       Date:  1999-06       Impact factor: 8.661

7.  Predictors of successful labor induction with oral or vaginal misoprostol.

Authors:  J M G Crane; T Delaney; K D Butt; K A Bennett; D Hutchens; D C Young
Journal:  J Matern Fetal Neonatal Med       Date:  2004-05

8.  Can the outcome of induction of labour with oral misoprostol be predicted.

Authors:  A M Mbele; J D Makin; R C Pattinson
Journal:  S Afr Med J       Date:  2007-04

9.  Misoprostol for uterine evacuation in patients with early pregnancy failures.

Authors:  Amanda Murchison; Patrick Duff
Journal:  Am J Obstet Gynecol       Date:  2004-05       Impact factor: 8.661

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.